Vivos Therapeutics, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Forfeitures
Vivos Therapeutics, Inc. (VVOS) reported Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Forfeitures of 11.00 thousand shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Forfeitures and Expirations
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures · last filed 2026-08-14
- Vivos Therapeutics, Inc. share-based compensation arrangement by share-based payment award, non-option equity instruments, forfeitures for the quarter ending 2025-12-31 was 16.00K shares.
- Vivos Therapeutics, Inc. share-based compensation arrangement by share-based payment award, non-option equity instruments, forfeitures for the quarter ending 2024-12-31 was 0.00 shares.
- Vivos Therapeutics, Inc. share-based compensation arrangement by share-based payment award, non-option equity instruments, forfeitures for the quarter ending 2024-09-30 was 0.00 shares.
- Vivos Therapeutics, Inc. share-based compensation arrangement by share-based payment award, non-option equity instruments, forfeitures for the quarter ending 2024-06-30 was 13.00K shares.
- Vivos Therapeutics, Inc. share-based compensation arrangement by share-based payment award, non-option equity instruments, forfeitures for fiscal 2025 was 751.00K shares, a 3029.17% increase from fiscal 2024.
- Vivos Therapeutics, Inc. share-based compensation arrangement by share-based payment award, non-option equity instruments, forfeitures for fiscal 2024 was 24.00K shares, a 52.00% decline from fiscal 2023.
- Vivos Therapeutics, Inc. share-based compensation arrangement by share-based payment award, non-option equity instruments, forfeitures for fiscal 2023 was 50.00K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Forfeitures 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Forfeitures 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Forfeitures 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Forfeitures 12 month |
|---|---|---|---|---|
| 2026-06-30 | 11.00K shares 10-Q · filed 2026-08-14 | |||
| 2025-12-31 | 16.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15 | 751.00K shares 10-K · filed 2026-04-15 | ||
| 2025-09-30 | 735.00K shares 10-Q · filed 2025-11-19 | |||
| 2024-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15 | 0.00 shares derived: sum of 2 quarters · filed 2026-04-15 | 13.00K shares derived: sum of 3 quarters · filed 2026-04-15 | 24.00K shares 10-K · filed 2026-04-15 |
| 2024-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | 13.00K shares derived: sum of 2 quarters · filed 2024-11-14 | 24.00K shares 10-Q · filed 2024-11-14 | |
| 2024-06-30 | 13.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | 24.00K shares 10-Q · filed 2024-08-14 | ||
| 2024-03-31 | 11.00K shares 10-Q · filed 2024-05-14 | |||
| 2023-12-31 | 50.00K shares 10-K · filed 2025-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |